Iodide iontophoresis as a treatment for dry eye syndrome

British Journal of Ophthalmology

Volumn 89, Issue 1, 2005, Pages 40-44

  Horwath Winter, Jutta ^a   Schmut, O ^a   Haller Schober, E M ^a   Gruber, A ^a   Rieger, G ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b A 4540   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

POLY(METHYL METHACRYLATE); SODIUM IODIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRY EYE; FEMALE; HUMAN; IONTOPHORESIS; KERATOCONJUNCTIVITIS SICCA; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIRMER TEST; SJOEGREN SYNDROME; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; DRY EYE SYNDROMES; FEMALE; FLUORESCEINS; FLUORESCENT DYES; HUMANS; IONTOPHORESIS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; ROSE BENGAL; SODIUM IODIDE; TREATMENT OUTCOME;

EID: 11144271371     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.048314     Document Type: Article

References (58)

1. Brewitt H, Sistani F. Dry eye disease: the scale of the problem. Surv Ophthalmol 2001;45:199-202.
2. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye. Arch Ophthalmol 2000;118:1264-8.
3. Schein OD, Munoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723-8.
4. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-9.
5. Augustin AJ, Spitznas M, Kaviani N, et al. Oxidative reactions in the tear fluid of patients suffering from dry eyes. Graefes Arch Clin Exp Ophthalmol 1995;233:694-8.
6. Debbasch C, Pisella PJ, Rat P, et al. Evaluation of free radical production by conjunctival impression cytology of patients treated with long-term antiglaucoma drugs or of contact lens wearers. J Fr Ophtalmol 2000;23:239-44.
7. Versura P, Profazio V, Cellini M, et al. Eye discomfort and air pollution. Ophthalmologica 1999;213:103-9.
8. Horwath J, Schmut O. The influence of environmental factors on the development of dry eye. Contactologica 2000;22:21-9.
9. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
10. McCord JM, Day ED Jr. Superoxide-dependent production of hydroxyl radicals catalysed by iron-EDTA complex. FEBS Lett 1978;86:139-42.
11. Conner EM, Grisham MB. Inflammation, free radicals and antioxidants. Nutrition 1996;12:274-7.
12. Crouch RK, Goletz P, Snyder A, et al. Antioxidant enzymes in human tears. J Ocul Pharmacol 1991;7:253-8.
13. Gogia R, Richer SP, Rose RC. Tear fluid content of electrochemically active components including water soluble antioxidants. Curr Eye Res 1998;17:257-63.
14. Choy CK, Benzie IF, Cho P. Ascorbic acid concentration and total antioxidant activity of human tear fluid measured using the FRASC assay. Invest Ophthalmol Vis Sci 2000;41:3293-8.
15. Fujihara T, Nagano T, Endo K, et al. Lactoferrin protects against UV-B irradiation-induced corneal epithelial damage in rats. Cornea 2000;19:207-11.
16. Schmut O, Gruber E, el-Shabrawi Y, et al. Destruction of human tear proteins by ozone. Free Radic Biol Med 1994;17:165-9.
17. Schmut O, Ansari AN, Faulborn J. Degradation of hyaluronate by the concerted action of ozone and sunlight. Ophthalmic Res 1994;26:340-3.
18. Mustafa MG. Biochemical basis of ozone toxicity. Free Rad Biol Med 1990;9:245-65.
19. Van der Vliet A, ONeill CA, Eiserich JP, et al. Oxidative damage to extracellular fluids by ozone and possible protective effects of thiols. Arch Biochem Biophys 1995;321:43-50.
20. Downes JE, Swann PG, Holmes RS. Ultraviolet light-induced pathology in the eye: associated changes in ocular aldehyde dehydrogenase and alcohol dehydrogenase activities. Cornea 1993;12:241-8.
21. Estil S, Olsen WM, Huitfeldt HS, et al. UVB-induced formation of (6-4) photoproducts in the rat corneal epithelium. Acta Ophthalmol Scand 1997;75:120-3.
22. Kennedy M, Kim KH, Harten B, et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci 1997;38:2483-91.
23. Gupta SK, Gupta V, Joshi S, et al. Subclinically dry eyes in urban Delhi: an impact of air pollution? Ophthalmologica 2002;216:368-71.
24. Debbasch C, De La Salle SB, Brignole F, et al. Cytoprotective effects of haluronic acid and carbomer 934P in ocular surface epithelial cells. Invest Ophthalmol Vis Sci 2002;43:3409-15.
25. Rieger G. Anti-oxidative capacity of various artificial tear preparations. Graefes Arch Clin Exp Ophthalmol 2001;239:222-6.
26. Venturi S, Donati FM, Venturi A, et al. Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Adv Clin Path 2000;4:11-17.
27. Winkler R, Moser M, Buchberger W. Die Wirksamkeit von Jodid als Sauerstoff-Radikalfänger. Wiss Z Humboldt Univ Berl R Med 1989;38:76-9.
28. Winkler R, Moser M, Buchberger W. Einfluß oraler balneotherapeutisch dosierter Jodsolezufuhr auf Harn-und Blutplasma-Jodid sowie auf Glutathlonspiegel und Aktivitäten korrespondierender Leberenzyme von Ratten. Z Phys Med Baln Klim 1989;18:129-36.
29. Winkler R, Moser M. Jodid. Ein potentielles Antioxidans und Sauerstoff-Radikalfänger und seine Rolle bei Peroxidase-Reaktionen. Vitaminspur 1992;7:124-34.
30. Moser M, Buchberger W, Maxer H, et al. Influence of an iodine-drinking cure on the antioxidative status of diabetes patients. Wien Klin Wochenschr 1991;103:183-0.
31. Rieger G, Griebenow S, Winkler R, et al. Der antioxidative Status der Tränenflüssigkeit vor und nach kombinierten Kurbehandlungen in Bad Hall. Spektrum Augenheilkd 2000;14:319-24.
32. Muronov K, Poliansky N, Winkler R, et al. Protection by iodide of lens from selenite-induced cataract. Graefes Arch Clin Exp Ophthalmol 2004;242:146-51.
33. Rieger G, Winkler R, Buchberger W, et al. Iodine distribution in a porcine eye model following iontophoresis. Ophthalmologica 1995;209:84-7.
34. Hagmüller K, Trichtel F. Autoradiographische Studien zur Jodanreicherung im Auge durch lontophorese. Ophthalmologica 1900;140:44-54.
35. Pommer H. The enrichment of the eye with iodine by iontophoresis. Wien Klin Wochenschr 1955;67:596-9.
36. Pommer H, Trichtel F. Comparative studies on radioiodine distribution in the eye after iontophoretic and intravenous administration. Albrecht Von Graefes Arch Ophthalmol 1956;158:81-6.
37. Hughes L, Maurice DM. A fresh look at iontophoresis. Arch Ophthalmol 1984;102:1825-9.
38. Hobden JA, Reidy JJ, O'Callaghan RJ, et al. Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis. Invest Ophthalmol Vis Sci 1990;31:1940-4.
39. Grossman RE, Chu DF, Lee DA. Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis. Invest Ophthalmol Vis Sci 1990;31:909-16.
40. Grossman R, Lee DA. Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye. Ophthalmology 1989;96:724-9.
41. Hill JM, Park NH, Gangorosa LP, et al. Iontophoresis of vidarabine monophosphate into rabbit eyes. Invest Ophthalol Vis Sci 1978;17:473-6.
42. Behar-Cohen FF, Parel JM, Pouliquen Y, et al. Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Exp Eye Res 1997;65:533-45.
43. Voigt M, Kralinger M, Kieselbach G, et al. Ocular aspirin distribution: a comparion of intravenous, topical, and coulomb-controlled iontophoresis administration. Invest Ophthalmol Vis Sci 2002;43:3299-306.
44. Tsubata K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999;83:390-5.
45. Van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10-14.
46. Tseng SC. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985;92:728-33.
47. Horwath-Winter J, Bergloeff J, Floegel I, et al. Botulinum toxin A treatment in patients suffering from blepharosposm and dry eye. Br J Ophthalmol 2003;87:54-6.
48. Erlanger G. Iontophoresis, a scientific and practical tool in ophthalmology. Ophthalmologica 1954;128:232-40.
49. Friedberg ML, Pleyer U, Mondino BJ. Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps. Ophthalmology 1991;98:725-32.
50. Berdugo M, Valamanesh F, Andrieu C, et al. Delivery of antisense oligonucleotide to the cornea by iontophoresis. Antisense Nucleic Acid Drug Dev 2003;13:107-14.
51. Duke Elder S. The method of administration of drugs. In: Duke Elder S, ed. System of ophthalmology. London: Henry Kimpton, 1962;VII:485-520.
52. Frucht-Pery J, Solomon A, Doron R, et al. Efficacy of iontophoresis in the rat cornea. Graefes Arch Clin Exp Ophthalmol 1996;234:765-9.
53. Behar-Cohen FF, ElAouni A, Gautier S, et al. Transscleral Coulomb-controlled iontophoresis of methylprednislolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels. Exp Eye Res 2002;74:51-9.
54. Hellauer H. Effect of iodine in an ERG-study on the isolated frog retina. Klin Monatsbl Augenheilkd 1972;161:63-6.
55. Rieger G, Winkler R, Stoiser E, et al. Zur subjektiven Befindlichkeit von Patienten mit Beschwerden des "trockenen Auges" vor und nach Absolvierung von Jodkurbehandlungen in Bad Hall. Spektrum Augenheilkd 1997;11:66-71.
56. Rieger G, Winkler R, Stoiser E. Zur Wirkungsdauer balneotherapeutischer Maßnahmen bei Patienten mit Beschwerden des "trockenen Auges". Spektrum Augenheilkd 1997;11:255-7.
57. Schmut O, Horwath-Winter J, Rieger G. Iodide protection from UVB irradiation induced degradation or hyaluronate and against UVB-damage of human conjunctival fibroblasts. Graefes Arch Clin Exp Ophthalmol 2004;242:279-83.
58. Farboud B, Nuccitelli R, Schwab IR, et al. DC electric fields induce rapid directional migration in human corneal epithelial cells. Exp Eye Res 2000;70:667-73.